title: Graft-appendiceal fistula treated with a rifampicin-silver in-situ graft.
abstract: BACKGROUND
  We report a 52-year-old male presenting with a graft-appendiceal fistula four years after placement of an aorto-bifemoral Dacron prosthesis.
  
  
  METHODS
  After appendectomy and total graft removal, the patient was treated with an in-situ repair using a rifampicin-silver graft. This kind of repair has only been reported in an animal study.
  
  
  RESULTS
  This infected aortic graft was treated successfully with a rifampicin-silver graft with a follow-up of 15 months without complications.
  
  
  CONCLUSIONS
  In-situ repair of a graft-appendiceal fistula with a rifampicin-silver graft seems a promising strategy. The long-term outcome needs to be studied.
authors.affiliation: Department of Vascular Surgery, University Medical Center Utrecht , Utrecht, The Netherlands .
authors.forename: Quirine M J
authors.initials: QM
authors.lastname: van der Vliet
authors.forename: Paul
authors.initials: P
authors.lastname: Berger
authors.forename: Gert Jan
authors.initials: GJ
authors.lastname: De Borst
authors.forename: Frans L
authors.initials: FL
authors.lastname: Moll
mesh_terms: D000287:Administration, Topical; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001064:Appendicitis / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D005402:Fistula / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000601:surgery*; D012293:Rifampin / Q000627:therapeutic use*; D012834:Silver / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D012834:Silver; D012293:Rifampin